Artemis Therapeutics (formerly known as New York Global Innovations) is a biopharmaceutical company that engages in the development of agents for the prevention and treatment of severe and potentially life-threatening infectious diseases. Its lead drug candidate, Artemisone, is a potent antiparasitic drug for the treatment of malaria.